Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Influence of 5-HTR2A genetic polymorphisms on the efficacy of antidepressants in the treatment of major depressive disorder: A meta-analysis
Jianyang Lin, Mingyan Jiang, Zhoumi Kan, et al.
Journal of Affective Disorders (2014) Vol. 168, pp. 430-438
Closed Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

The Implication of 5-HT Receptor Family Members in Aggression, Depression and Suicide: Similarity and Difference
Н. К. Попова, А. С. Цыбко, В. С. Науменко
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8814-8814
Open Access | Times Cited: 50
Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response
Chiara Fabbri, Ladislav Hosák, Rainald Mößner, et al.
The World Journal of Biological Psychiatry (2016) Vol. 18, Iss. 1, pp. 5-28
Open Access | Times Cited: 79
Genetic variants in major depressive disorder: From pathophysiology to therapy
Xénia Gonda, Péter Petschner, Nóra Eszlári, et al.
Pharmacology & Therapeutics (2018) Vol. 194, pp. 22-43
Open Access | Times Cited: 76
Small Extracellular Vesicles in Rat Serum Contain Astrocyte-Derived Protein Biomarkers of Repetitive Stress
Cristóbal Gómez-Molina, Mauricio Sandoval, Roberto Henzi, et al.
The International Journal of Neuropsychopharmacology (2018) Vol. 22, Iss. 3, pp. 232-246
Open Access | Times Cited: 72
Pet-1 Switches Transcriptional Targets Postnatally to Regulate Maturation of Serotonin Neuron Excitability
Steven C. Wyler, William C. Spencer, Noah H. Green, et al.
Journal of Neuroscience (2016) Vol. 36, Iss. 5, pp. 1758-1774
Open Access | Times Cited: 63
Genetic correlates of spirituality/religion and depression: A study in offspring and grandchildren at high and low familial risk for depression.
Micheline R. Anderson, Lisa Miller, Priya Wickramaratne, et al.
Spirituality in Clinical Practice (2017) Vol. 4, Iss. 1, pp. 43-63
Open Access | Times Cited: 62
Pharmacogenetics of Sertraline Tolerability and Response in Pediatric Anxiety and Depressive Disorders
Ethan A. Poweleit, Stacey L. Aldrich, Lisa J. Martin, et al.
Journal of Child and Adolescent Psychopharmacology (2019) Vol. 29, Iss. 5, pp. 348-361
Closed Access | Times Cited: 39
Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach
Gaël Qesseveur, Anne‐Cécile Petit, Hai Thanh Nguyen, et al.
Neuropharmacology (2016) Vol. 105, pp. 142-153
Closed Access | Times Cited: 37
Progress and prospects in pharmacogenetics of antidepressant drugs
Chiara Fabbri, Concetta Crisafulli, Marco Calabrò, et al.
Expert Opinion on Drug Metabolism & Toxicology (2016) Vol. 12, Iss. 10, pp. 1157-1168
Closed Access | Times Cited: 37
Blood-based biomarkers predicting response to antidepressants
Yasmin Busch, Andreas Menke
Journal of Neural Transmission (2018) Vol. 126, Iss. 1, pp. 47-63
Closed Access | Times Cited: 31
Potential Mechanisms Underlying the Therapeutic Effects of Electroconvulsive Therapy
Jiangling Jiang, Jijun Wang, Chunbo Li
Neuroscience Bulletin (2016) Vol. 33, Iss. 3, pp. 339-347
Open Access | Times Cited: 29
The establishment of the objective diagnostic markers and personalized medical intervention in patients with major depressive disorder: rationale and protocol
Xiaozhen Lv, Tianmei Si, Gang Wang, et al.
BMC Psychiatry (2016) Vol. 16, Iss. 1
Open Access | Times Cited: 28
Genome-wide association study of antidepressant response: involvement of the inorganic cation transmembrane transporter activity pathway
Enrico Cocchi, Chiara Fabbri, Hans‐Jürgen Möller, et al.
BMC Psychiatry (2016) Vol. 16, Iss. 1
Open Access | Times Cited: 27
TPH-2 Polymorphisms Interact with Early Life Stress to Influence Response to Treatment with Antidepressant Drugs
Zhi Xu, Gavin P. Reynolds, Yonggui Yuan, et al.
The International Journal of Neuropsychopharmacology (2016) Vol. 19, Iss. 11, pp. pyw070-pyw070
Open Access | Times Cited: 27
5-HT2A Gene Variants Moderate the Association between PTSD and Reduced Default Mode Network Connectivity
Mark W. Miller, Emily Sperbeck, Meghan E. Robinson, et al.
Frontiers in Neuroscience (2016) Vol. 10
Open Access | Times Cited: 26
Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial
André R. Brunoni, Ángel Carracedo, Olalla Maroñas, et al.
Brazilian Journal of Psychiatry (2019) Vol. 42, Iss. 2, pp. 128-135
Open Access | Times Cited: 25
Overview of pharmacogenomic testing in clinical practice
Tonya Gross, Jeremy Daniel
Mental Health Clinician (2018) Vol. 8, Iss. 5, pp. 235-241
Open Access | Times Cited: 23
<em>5-HTR1A</em> and <em>5-HTR2A </em>genetic polymorphisms and SSRI antidepressant response in depressive Chinese patients
Xueli Sun, Xirong Li, Lin He, et al.
Neuropsychiatric Disease and Treatment (2016) Vol. Volume 12, pp. 1623-1629
Open Access | Times Cited: 22
Rostral Anterior Cingulate Thickness Predicts the Emotional Psilocybin Experience
Candace R. Lewis, Katrin H. Preller, B. Blair Braden, et al.
Biomedicines (2020) Vol. 8, Iss. 2, pp. 34-34
Open Access | Times Cited: 19
Neuroplasticity, Neurotransmission and Brain-Related Genes in Major Depression and Bipolar Disorder: Focus on Treatment Outcomes in an Asiatic Sample
Marco Calabrò, Laura Mandelli, Concetta Crisafulli, et al.
Advances in Therapy (2018) Vol. 35, Iss. 10, pp. 1656-1670
Open Access | Times Cited: 19
Gene-Based Association Analysis Suggests Association of HTR2A With Antidepressant Treatment Response in Depressed Patients
Chung-Feng Kao, Po‐Hsiu Kuo, Younger W.‐Y. Yu, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 16
Pharmacogenetics and Imaging–Pharmacogenetics of Antidepressant Response: Towards Translational Strategies
Tristram A. Lett, Henrik Walter, Eva J. Brandl
CNS Drugs (2016) Vol. 30, Iss. 12, pp. 1169-1189
Closed Access | Times Cited: 17
Interactions Among Polymorphisms of Susceptibility Loci for Alzheimer’s Disease or Depressive Disorder
Eva Kitzlerová, Zdeněk Fišar, Petra Lelková, et al.
Medical Science Monitor (2018) Vol. 24, pp. 2599-2619
Open Access | Times Cited: 17
Genetic variation in the tryptophan hydroxylase 2 gene moderates depressive symptom trajectories and remission over 8 weeks of escitalopram treatment
Yun‐Ai Su, Jitao Li, Wenji Dai, et al.
International Clinical Psychopharmacology (2016) Vol. 31, Iss. 3, pp. 127-133
Closed Access | Times Cited: 15
Further Support for the Involvement of Genetic Variants Related to the Serotonergic Pathway in the Antidepressant Response in Children and Adolescents After a 12-Month Follow-Up: Impact of the HTR2A rs7997012 Polymorphism
Patricia Gassó, Ana Blázquez, Natàlia Rodríguez, et al.
Journal of Child and Adolescent Psychopharmacology (2018) Vol. 28, Iss. 10, pp. 711-718
Closed Access | Times Cited: 16
Page 1 - Next Page

Scroll to top